InnovAge
INNV
$3.80
Share price
-4.76%
Change (1 day)
-38.31%
Change (1 year)
Categories
InnovAge (INNV) - P/B ratio
P/B ratio as of April 2024 : 1.79
According to InnovAge's latest financial reports the company has a price-to-book ratio of 1.79.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
InnovAge - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.69 | -8.28% |
| 2022-12-31 | 2.93 | 59.53% |
| 2021-12-31 | 1.84 | |
| 2020-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Merck MRK | 8.55 | 377.60% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | 0.5158 | -71.18% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 1.03 | -42.25% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | 5.01 | 180.19% | 🇮🇪 Ireland |